Abstract
Bifurcations are a challenging lesion subset for percutaneous coronary intervention. In the RESOLUTE ONYX Bifurcation study, we evaluated the 2-year clinical outcomes of patients with bifurcation lesions treated with the Resolute Onyx zotarolimus-eluting stent (ZES).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Society for Cardiovascular Angiography & Interventions
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
